Tables for:
Safety and Immunogenicity of Meningococcus Serogroup C Conjugate Vaccine Administered as a Primary or Booster Vaccination to Healthy Four-Year-Old Children
[Pediatr Infect Dis J 21(8):747-753, 2002. © 2002 Lippincott Williams & Wilkins]
Table 1. Subject flowchart
Table 2. Immunogenicity of meningococcus serogroup C conjugate vaccine at 4 years of age
Table 3. Summary of local reactions
